4.7 Article

Structural analysis of the regulatory mechanism of MarR protein Rv2887 in M-tuberculosis

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-017-01705-4

关键词

-

资金

  1. National Basic Research Program of China [2011CB910300, 2013CB911500]
  2. Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health [2013ZX10003006]
  3. National Natural Science Foundation of China [31170132, U1401224]
  4. Chinese Academy of Sciences [KJZD-EW-TZ-L04, XDB08020200]
  5. Youth Innovation Promotion Association of the Chinese Academy of Sciences
  6. Special Fund for Public Welfare Research and Capacity Building in Guangdong Province [2014B030301002]
  7. Guangdong Innovative and Entrepreneurial Research Team Program [201301S0105384179]

向作者/读者索取更多资源

MarR family proteins are transcriptional regulators that control expression of bacterial proteins involved in metabolism, virulence, stress responses and multi-drug resistance, mainly via ligandmediated attenuation of DNA binding. Greater understanding of their underlying regulatory mechanism may open up new avenues for the effective treatment of bacterial infections. To gain molecular insight into the mechanism of Rv2887, a MarR family protein in M. tuberculosis, we first showed that it binds salicylate (SA) and para-aminosalicylic acid (PAS), its structural analogue and an antitubercular drug, in a 1: 1 stoichiometry with high affinity. Subsequent determination and analysis of Rv2887 crystal structures in apo form, and in complex with SA, PAS and DNA showed that SA and PAS bind to Rv2887 at similar sites, and that Rv2887 interacts with DNA mainly by insertion of helix alpha 4 into the major groove. Ligand binding triggers rotation of the wHTH domain of Rv2887 toward the dimerization domain, causing changes in protein conformation such that it can no longer bind to a 27 bp recognition sequence in the upstream region of gene Rv0560c. The structures provided here lay a foundation for the design of small molecules that target Rv2887, a potential new approach for the development of anti-mycobacterials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据